Fraunhofer-Gesellschaft
Fraunhofer-Gesellschaft

Press Kit for MEDICA 2021

Fraunhofer is presenting the results of its research on the MEDICA and COMPAMED 2021 from 15 to 18 November in Düsseldorf. Visit the joint Fraunhofer booths:

Hall 3, Booth E74

Hall 13 , Booth D60

Press Releases

 

© Fraunhofer IBMT

Safe, patient-friendly implants for personalized therapy

Implants can actively support the body, as in the case of pacemakers, neuroprostheses or cochlear implants. In the future, active implants will be smaller, less energy-intensive and, above all, more patient-friendly. This is why the Fraunhofer IBMT is working on miniaturization, external power supplies and wirelessly networked implants.

Press Release
 

© Fraunhofer IPM

New methods for detecting single molecules

Resistance to antibiotics is on the rise worldwide. Researchers at the
Fraunhofer Institute for Physical Measurement Techniques IPM alongside the Ludwig Maximilian University of Munich have developed a process for rapidly detecting multidrug-resistant pathogens. The unique feature: Even one single molecule of DNA is sufficient for pathogen detection.

Press Release
 

© Fraunhofer IAP

From medical applications to sporting goods – biocompatible and sustainable plastics

Numerous plastic products are made of polyurethanes. Fraunhofer researchers have developed a manufacturing method for polyurethanes that avoids use of toxic isocyanates while making use of carbon dioxide as a starting material.

Press Release
 

© Fraunhofer IOF

3D printing for optical components

At the COMPAMED 2021 trade fair the Fraunhofer Institute for Applied Optics and Precision Engineering IOF will present cost-efficient manufacturing processes for "lab-on-a-chip" systems as well as technologies for 3D printing of optical components from November 15 to 18.  

 

 

© Fraunhofer IBMT/Bernd Müller

Stem cells from the bioreactor

With the aid of artificial stem cells, it will soon be possible to establish new treatments for previously incurable diseases such as Alzheimer’s disease. At the Fraunhofer Project Center for Stem Cell Process Engineering SPT, a process for the mass production of these so called induced pluripotent stem cells is being developed. This process involves new materials, which ensure that industrial cell production will meet high quality standards.

PRESS RELEASE
 

© Fraunhofer IAP/Till Budde

Personalized medicine: 3D printing enables tissue with customized shape

In the case of serious soft tissue injuries, tissue transplantation is sometimes unavoidable. For the patient, however, this means a serious intervention. In the future, the missing tissue could grow directly in the patient's body - in isolation chambers that can be implanted under the skin and individually adapted to the wound geometry.